Cipla Medpro, Cipla's South African arm, signed an agreement with Serum Institute of India (SII) to sell vaccines in South Africa, Cipla said on Thursday. According to Cipla Medpro's CEO Paul Miller, the agreement will help Cipla grow in the South African market. Serum Institute manufactures vaccines for Polio, Diphtheria, Tetanus, Hepatitis B, etc. 